COPD Pal Phase 2: A self-management app for Chronic Obstructive Pulmonary Disease. A pilot study
Not Applicable
Completed
- Conditions
- Chronic obstructive pulmonary diseaseRespiratory
- Registration Number
- ISRCTN14530045
- Lead Sponsor
- Hywel Dda University Health Board
- Brief Summary
2021 Results article in https://doi.org/10.1007/s12553-021-00534-w (added 11/11/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
1. Willing and able to sign informed consent
2. Clinical diagnosis of COPD as defined by GOLD, i.e. greater than 40 years old, =10 pack years smoking history, post-bronchodilator FEV1/FVC ratio of 0.7, with FEV1 less than 80% predicted
3. Life expectancy greater than 6 months
Exclusion Criteria
1. Cognitive, visual, or motor impairment that would affect ability to see or use a smart phone
2. Current hospital inpatient or nursing home resident
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Acceptable recruitment is defined as >50% of eligible people consenting to participate and follow-up data available for the self-management questionnaire (UCOPD) for >60% of enrolled participants at the end of the study period<br>2. Engagement will be measured in terms of active use of the App. Participant use will be automatically collected by COPD Pal and acceptable engagement defined as over 70% using app daily<br>3. Safety will be measured as the mean number of exacerbations or hospitalisations and deemed acceptable if not 20% more in the 3 months whilst using the app than the 3 months immediately pre-app. (GP contact and steroid/antibiotic use may increase as a result of better patient awareness of symptoms and as such will not be used as an indicator of safety)
- Secondary Outcome Measures
Name Time Method 1. HRQoL measured using the COPD Assessment Test at baseline and weekly within the app for 6 weeks<br>2. Impact of the app on self-management confidence measured using the UCOPD questionnaire at baseline and 6 weeks